Antibacterial activity of cefquinome against equine bacterial pathogens

Veterinary Microbiology

Volumn 115, Issue 1-3, 2006, Pages 140-147

  Thomas, E ^a   Thomas, V ^a   Wilhelm, C ^a  

^a Intervet Innovation GmbH   (Germany)

Author keywords

Antibiotic; Cefquinome; Horse

Indexed keywords

CEFQUINOME;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; ESCHERICHIA COLI; EUROPE; HORSE; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS; RESPIRATORY TRACT INFECTION; RHODOCOCCUS; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; HORSE DISEASES; HORSES; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

ACTINOBACILLUS EQUULI; BACTERIA (MICROORGANISMS); BOS TAURUS; ENTEROBACTERIACEAE; EQUIDAE; ESCHERICHIA COLI; PSEUDOMONAS; RHODOCOCCUS; STAPHYLOCOCCUS;

EID: 33646879596     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2005.12.019     Document Type: Article

References (22)

1. Albihn A., Baverud V., and Magnusson U. Uterine microbiology and antimicrobial susceptibility in isolated bacteria from mares with fertility problems. Acta Vet. Scand. 44 (2003) 121-129
2. Anonymous, 2004. Position paper regarding availability of products for minor uses and minor species (MUMS). EMEA/CVMP/477/03/Final.
3. AVID (Arbeitskreis für veterinärmedizinische Infecktionsdiagnostik), 1999. Appendix 40, 5.
4. Boettner A., Schmid P., and Humke R. In vitro efficacy of cefquinome (INN) and other antiinfective drugs against bovine bacterial isolates from Belgium, France, Germany, The Netherlands and the United Kingdom. J. Vet. Med. B42 (1995) 377-383
5. Brewer B.D., and Koterba A.M. The diagnosis and treatment of equine neonatal septicaemia. Proc. Am. Ass. Equine Pract. (1985) 127-135
6. Bryskier A. New concepts in the field of cephalosporins: C-3′ quaternary ammonium cephems (Group IV). Clin. Microbiol. Infect. 3 Suppl. 1 (1997) S1-S6
7. Clinical and Laboratory Standards Institute (CLSI, formerly National Committee for Clinical Laboratory Standards), 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. M26-A, Wayne, PA.
8. Clinical and Laboratory Standards Institute (CLSI, formerly National Committee for Clinical Laboratory Standards), 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. M31-A2, Wayne, PA
9. Clinical and Laboratory Standards Institute (CLSI, formerly National Committee for Clinical Laboratory Standards), 2003. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. M11-A5, Wayne, PA.
10. Craig W.A. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis. 22 (1995) 89-96
11. Craig W., and Gudmundsson S. The postantibiotic effect. In: Lorian V. (Ed). Antibiotics in Laboratory Medicine (1996), Williams & Wilkins Co., Baltimore 296-329
12. Giguere S., and Sweeney C.R. Antimicrobial drug use in horses. In: Prescott J.F., Baggot J.D., and Walker R.D. (Eds). Antimicrobial Therapy (2000), Iowa State University Press, Ames 509-536
13. Limbert M., Isert D., Klesel N., Markus A., Seeger K., Seibert G., and Schrinner E. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 35 (1991) 14-19
14. Marsh P.S., and Palmer J.E. Bacterial isolates from blood and their susceptibility patterns in critically ill foals: 543 cases (1991-1998). JAVMA 218 (2001) 1608-1610
15. Murphy S.P., Erwin M.E., and Jones R.N. Cefquinome (HR 111V). In vitro evaluation of a broad spectrum cephalosporin indicated for infections in animals. Diagn. Microbiol. Infect. Dis. 20 (1994) 49-55
16. Odenholt I. Review pharmacodynamic effects of subinhibitory antibiotic concentrations. Intern. J. Antimicrob. Agents 17 (2001) 1-8
17. Odenholt-Tornqvist I., Lödwin E., and Cars O. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36 (1992) 1852-1858
18. Rose M., Thomas V., and Nordmann P. In vitro activity of third and fourth generation cephalosporins against E. coli strains expressing plasmid-encoded AmpC cephalosporinases. Risk Management for the Limitation of Antibiotic Resistance, Scientific Symposium. 15-16 November 2004 (2004), Federal Office of Consumer Protection and Food Safety, Berlin, Germany
19. SVARM. Swedish Veterinary Antimicrobial Resistance Monitoring 2002 (2003), Department of Antibiotics, National Veterinary Institute, Uppsala, Sweden
20. Sweeney C.R., Sweeney R.W., and Benson C.E. Comparison of bacteria isolated from specimens obtained by use of endoscopic guarded tracheal swabbing and percutaneous tracheal aspiration in horses. JAVMA 195 9 (1989) 1225-1229
21. Trolldenier H., and Kempf G. Zur Resistenz bakterieller Erreger vom Pferd aus bundesweit erfassten Daten und Schlussforderungen. Der Praktische Tierarzt 81 3 (2000) 216-231
22. Wood J.L.N., Burrell M.H., Roberts C.A., Chanter N., and Shaw Y. Streptococci and Pasteurella spp. associated with disease of the equine lower respiratory tract. Equine Vet. J. 25 4 (1993) 314-318